Canada markets open in 4 hours 15 minutes

Adaptive Biotechnologies Corporation (ADPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.4400-0.3100 (-11.27%)
At close: 04:00PM EDT
2.5000 +0.06 (+2.46%)
After hours: 07:53PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 352.57M
Enterprise Value 104.95M
Trailing P/E 43.96
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.06
Price/Book (mrq)1.14
Enterprise Value/Revenue 0.62
Enterprise Value/EBITDA -0.55

Trading Information

Stock Price History

Beta (5Y Monthly) 1.24
52-Week Change 3-70.71%
S&P500 52-Week Change 321.61%
52 Week High 39.0800
52 Week Low 32.4300
50-Day Moving Average 33.4178
200-Day Moving Average 34.8815

Share Statistics

Avg Vol (3 month) 31.61M
Avg Vol (10 day) 32.22M
Shares Outstanding 5145.09M
Implied Shares Outstanding 6145.09M
Float 896.82M
% Held by Insiders 12.83%
% Held by Institutions 197.60%
Shares Short (Mar 28, 2024) 49.1M
Short Ratio (Mar 28, 2024) 45.8
Short % of Float (Mar 28, 2024) 48.04%
Short % of Shares Outstanding (Mar 28, 2024) 46.27%
Shares Short (prior month Feb 29, 2024) 48.77M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -132.28%
Operating Margin (ttm)-99.68%

Management Effectiveness

Return on Assets (ttm)-16.60%
Return on Equity (ttm)-58.34%

Income Statement

Revenue (ttm)170.28M
Revenue Per Share (ttm)1.18
Quarterly Revenue Growth (yoy)-17.10%
Gross Profit (ttm)N/A
EBITDA -179.38M
Net Income Avi to Common (ttm)-225.25M
Diluted EPS (ttm)-1.5600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)346.4M
Total Cash Per Share (mrq)2.39
Total Debt (mrq)229.43M
Total Debt/Equity (mrq)74.42%
Current Ratio (mrq)4.66
Book Value Per Share (mrq)2.13

Cash Flow Statement

Operating Cash Flow (ttm)-156.32M
Levered Free Cash Flow (ttm)-81.95M